PBKM plans to take over other companies

The Polish Stem Cell Bank (PBKM) has more than ten acquisition targets, but the funds from the December issue of shares (PLN 53 million) will not be enough to take over all of them. “The company is already looking for new sources of financing,” president Jakub Baran said on Wednesday. PBKM will consider taking out a bank loan, it also does not exclude a share issue. The company is looking at both European and non-European acquisition targets.

In May last year, PBKM bought the Swiss company, Biocell Lugano. In September 2018, it took over the Portuguese Stemlab group, and in January this year it signed an agreement for the purchase of a 95 percent stake in the Spanish company, IVI Cordon.
(PAP)